Streamline your RNA knockdown projects with our comprehensive, end-to-end solutions. From precise target identification and custom molecule design to optimized delivery systems, our Anticlastic technology and advanced methodologies provide the ability to significantly reduce gene expression with unmatched accuracy.
Our workflow ensures seamless integration into your research pipeline, featuring AI powered antisense oligonucleotide (ASO) design, identification and optimization of lead sequences using in vitro and in vivo assays, safety evaluations and pre-clinical development.
Accelerate your discoveries with our precise and reliable RNA knockdown functional studies. From target gene selection to advanced phenotypic analysis, our expert team designs and executes tailored studies to uncover how genes influence cellular processes, pathways, and disease mechanisms. Whether validating therapeutic targets or mapping complex pathways, our solutions will provide actionable insights and data.
Advance your way to impactful therapies with validation offerings that are designed to give you confidence in the effectiveness and safety of your RNA knockdown therapy. We ensure the success of the treatment with a combination of molecular, cellular, and in-vivo assays to confirm therapeutic effectiveness and specificity. From mRNA and protein suppression analysis, our experts provide end-to-end support for your therapeutic candidates. We are well equipped to assess safety, toxicity, and off-target effects to ensure your treatment meets the highest standards.
Modalities
Ecosystem
Company
Insights
© 2025 Alloy Therapeutics, Inc. All Rights Reserved.
